Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Corcoran

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 29, 2011
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression studyKatherine A Treiber, Michelle C Carlson, Chris Corcoran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2013
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression StudyDavid Peterson, Caitlin Munger, Jared Crowley, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 7, 2004
ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilageLisa A Collins-Racie, Carl R Flannery, Weilan Zeng, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 29, 2011
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression studyKatherine A Treiber, Michelle C Carlson, Chris Corcoran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2013
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression StudyDavid Peterson, Caitlin Munger, Jared Crowley, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 7, 2004
ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilageLisa A Collins-Racie, Carl R Flannery, Weilan Zeng, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 4